Gastric cancer is the fourth most common cancer and the second leading cause of cancer
deaths worldwide. Chemotherapy is one of the major treatments for gastric cancer, but drug …

Simple Summary One-third of the approximately 10 million deaths yearly caused by cancer
worldwide are due to hepatobiliary, pancreatic, and gastrointestinal tumors. One primary …

Background P‐glycoprotein, the gene product of MDR1, confers multidrug resistance
against antineoplastic agents but also plays an important role in the bioavailability of …

Gastric cancer is the second leading cause of cancer mortality worldwide. The major cause
of treatment failure for gastric cancer is the development of multidrug resistance (MDR) to …

Gastric cancer is still the second leading cause of cancer death worldwide. Chemotherapy is
one of the major treatment options for advanced gastric cancer. The efficacy of …

Despite the significant recent advances in clinical practice, gastric cancer (GC) represents a
leading cause of cancer-related deaths in the world. In fact, occurrence of chemo-resistance …

Multidrug resistance (MDR) remains a significant challenge to the clinical treatment of
gastric cancer (GC). In the present study, using a phage display approach combined with …

Background Cholangiocellular carcinomas and gallbladder carcinomas are highly
aggressive tumours with a poor prognosis and are generally regarded as chemoresistant …

AIM: To isolate and clone the vincristine-resistine-related genes in gastric cancer SGC7901
cell line and to clarify the multidrug-resistant molecular mechanism of gastric cancer cells …

Abstract Background Calcyclin-binding protein (CacyBP) was previously identified as an
upregulated gene in a multidrug-resistant gastric cancer cell line, SGC7901/ADR, compared …